Health Economics

Nerivio also demonstrated notable health economics and outcomes benefits in both acute and preventive migraine care. Nerivio lead to consistent reductions in medication use, migraine-related disability, productivity loss, and associated costs, across multiple studies, while maintaining high patient satisfaction and safety, making it a compelling treatment option in Health Economics and Outcomes Research (HEOR) terms for patients, providers, and payers alike.